ICER says drug price hikes without proof of new benefits cost U.S. $5.1b

ICER says drug price hikes without proof of new benefits cost U.S. $5.1b

More reads

• ICER says price hikes on 7 drugs were made without proof of new benefits, costing the U.S. $5.1 billion. (STAT Plus)
• ICER’s concern for patients: Where’s the beef? (STAT)
• Soylent co-founder seeks to raise biotech venture capital fund. (Wall Street Journal)